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Abstract 
Background: Quality of life can be perceived as a subjective assessment of different aspects of human function‑
ing. Personality is a factor which determines actions taken by individuals and their tendency to perceive reality in a 
particular way. Therefore, the assumption that personality may influence the QoL assessment seems reasonable. Our 
purpose was to assess the relationships between personality traits and the presence of the 44‑bp VNTR polymor‑
phism in the 5‑HTT (SLC 6A4) promoter region and the 30‑bp VNTR polymorphism in the MAO‑A promoter region. We 
also wanted to determine the influence of personality on the quality of life of postmenopausal women.
Methods: The study involved 214 postmenopausal women from northwest Poland. It was conducted using the 
NEO‑FFI and the SF‑36 questionnaires. DNA polymorphisms were identified using the polymerase chain reaction 
(PCR).
Results: The average age of the women was 56.8 ± 4.08 years. Half of the respondents had completed second‑level 
education, 69.2 % had life partners, and 53.3 % were professionally active. Women with the 3/3 genotype were char‑
acterized by significantly lower openness to experience than respondents with other MAO‑A genotypes (p < 0.05). 
There was a significant correlation between the quality of life and the levels of neuroticism and extroversion, as well as 
between selected quality of life domains and the levels of agreeableness and conscientiousness.
Conclusions: (1)Women with the 3/3 genotype of the 30‑bp VNTR polymorphism in the MAO‑A promoter region are 
characterized by lower levels of openness to experience than women with other MAO‑A genotypes in our study (2) 
Personality traits may contribute to the assessment of the quality of life.
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Background
The postmenopausal period is a special time in a wom-
an’s life—the time which entails progressive deterioration 
in the quality of life, leading as a consequence to lower 
physical activity, withdrawal from social life and unwill-
ingness to develop. When analyzing inconveniences of 
the perimenopausal period, special attention should 
be paid to the fact that as many as 90 % of women suf-
fer from mental disorders manifested by sudden mood 
changes, difficulties in coping with stress in everyday life, 
depressed mood, getting tired quickly, restlessness and 
irritation, as well as concentration problems, the weak-
ening of memory, treatment unresponsive somatic com-
plaints, and full-blown depression [1, 2]. The mechanism 
of developing mental disorders in the perimenopausal 
period has not been so far fully elucidated. It has not 
been unambiguously established whether lower mood, 
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tension, and concentration problems are associated with 
changes in hormone metabolism, or whether they result 
from the configuration of psychosocial factors. A decline 
in the estrogen level results in vasomotor symptoms—
such as hot flushes, sweats, and headache—which nega-
tively affect the quality of women’s lives, causing sleep 
and concentration problems, oversensitivity, fatigue, 
and melancholy [3]. According to some reports, depres-
sion occurs mainly in those perimenopausal women who 
are predisposed to it and who have already experienced 
depressive episodes. The level of estrogen may contribute 
to depressive symptoms in the early stages of menopause, 
which suggests that a sudden drop in the estrogen level 
increases a risk of depressive disorders. It would explain 
the lack of relationship between depression and gradually 
decreasing estrogen levels in postmenopausal women. 
Depression in the postmenopausal period seems to have 
different aetiology [4, 5]. It is believed that the monoam-
ine imbalance, which modifies the expression of traits, 
mental functions and behaviour, may contribute to mood 
disorders [6]. Scientists identified genes that may have 
the most profound effects on the metabolism of mono-
amine neurotransmitters, such as serotonin (5-HT) and 
monoamine oxidase A (MAO-A). The expression of these 
genes depends on the type of polymorphism potentially 
contributing to the occurrence of specific mood dis-
orders. The serotonin transporter (5-HTT) gene (SLC 
6A4) polymorphism is characterized by the insertion or 
deletion of a 44-bp fragment, and thus, the creation of 
the long (l) allele and the short (s) allele. The presence 
of the ‘s’ allele of the 5-HTT gene is presumably associ-
ated with a lower gene expression and worse function-
ing of the serotonin transporter, which in turn disturbs 
neurotransmission and results in a higher tendency to 
anxiety and avoidant behaviours [7, 8]. It has also been 
proved that the ‘s’ allele involves lower serotonergic flex-
ibility and as a consequence impulsive behaviours [9]. 
MAO-A is an enzyme involved in the degradation of bio-
genic amines. Until now, researchers have mainly focused 
on the functional VNTR polymorphism in the promoter 
region of the gene encoding this enzyme. It consists of a 
30-bp repeated sequence that may be present in 3, 3.5, 4, 
or 5 copies. The ‘3’ allele is associated with a lower, and 
the ‘3.5’, ‘4’, and ‘5’ alleles—with a higher gene transcrip-
tional activity. The MAO-A gene may be responsible for 
an inclination to depression [10].
Based on analysis of the correlations between person-
ality traits of monozygotic and dizygotic twins, and the 
phenomenon of sharing personality traits with brothers 
and sisters in biological and adoptive families, behav-
ioural geneticists proved that the occurrence of simi-
lar personality traits within one family is determined by 
genetic factors. Personality consists of several dimensions 
or characteristics, which have a normal distribution in 
the general population. Personality is defined as an indi-
vidual’s unique behavioural pattern. There are significant 
interindividual differences in reacting to changes in the 
external and internal environment. According to McCrae 
and Costa there are five personality dimensions: Neuroti-
cism, Extroversion, Openness to experience, Agreeable-
ness, and Conscientiousness [11].
At present, quality of life is the most dynamically devel-
oping and increasingly described measure of health. It 
defines the level of self-realization and satisfaction with 
life from a holistic perspective [12]. In the case of peri-
menopausal women, several aspects of QoL can be dis-
cussed, namely the subjective perception of one’s position 
in life, health status, as well as physiological changes and 
their consequences [13–15]. Somatic and psychological 
complaints usually change people’s views of their QoL. 
Currently, a lot of attention is devoted to the concept of 
health-related quality of life (HRQoL), which covers four 
domains: physical functioning, mental functioning, social 
functioning, and symptoms associated with the patho-
logical and therapeutic processes. Self-reported QoL may 
change with time and under the influence of objective 
factors [16, 17]. Personality significantly determines the 
QoL assessment both among healthy patients, and those 
with somatic and/or mental disorders [18].
The purpose of this study was to determine how per-
sonality traits of postmenopausal women are related to 
the presence of the 44-bp VNTR polymorphism in the 
5-HTT (SLC 6A4) promoter region and the 30-bp VNTR 
polymorphism in the MAO-A promoter region. We 
wanted also to establish the influence of personality on 
self-reported quality of life.
Methods
Our research involved 214 healthy women, living in 
northwest Poland. All participants gave informed con-
sent to take part in the study and their anonymity was 
preserved. The inclusion criteria were at least 1  year 
after the last menstruation, no alcohol abuse, no smok-
ing, no endocrine disorders, no neoplastic diseases, and 
no current or past history of psychiatric treatment. To 
exclude mental disorders in the study group, all women 
were screened by means of the Primary Care Evalua-
tion of Mental Disorders Patient Heath Questionnaire 9 
(PRIME-MD PHQ-9) prior to the study. The PRIME-MD 
questionnaire concerns all criteria for depression diagno-
sis, and includes a gradual scale for measuring the sever-
ity of symptoms.
The first stage of the study was based on a survey per-
formed using standard research instruments, namely 
the Neuroticism-Extroversion-Openness-Five Factor 
Inventory (NEO-FFI) and the Short Form Health Survey 
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(SF-36) for measuring quality of life. The NEO-FFI is 
applied to analyze personality traits included in the Five 
Factor Model. The questionnaire consists of five scales 
measuring: neuroticism, extroversion, openness to expe-
rience, agreeableness and conscientiousness. Sixty self-
descriptive statements are answered on a five-point scale. 
The points obtained for each of the NEO-FFI scales are 
summed up, thus giving the score: high (7–10), average 
(4–6), or low (1–3) for each of the five scales. The ques-
tionnaire was adapted into Polish by Bogdan Zawadzki, 
Jan Strelau, Piotr Szczepaniak, and Magdalena Śliwińska 
in 1998. The Short Form Health Survey (SF-36) serves 
for measuring quality of life. It consists of 11 questions, 
including 36 statements, divided into subscales measur-
ing eight aspects of QoL, namely physical functioning, 
role physical, bodily pain, general health, vitality, social 
functioning, role emotional, and mental health.
The second stage of the study was based on genetic 
tests. For genetic analysis 10  ml venous blood samples 
were collected with the Vacutainer. Biological mate-
rial (blood) was collected and stored in accordance with 
the principles of the quality management system of the 
Genetic Laboratory, the Department of Psychiatry. DNA 
was isolated from whole blood by the salting-out method 
of Miller. Polymerase chain reaction (PCR) was used to 
identify DNA polymorphisms. The aim of the analysis 
was to amplify the fragment consisting of 2–5 repetitions 
of the 30-bp VNTR polymorphism in the MAO-A pro-
moter region. The following primer sequences were used: 
MAO-A F: 5′ CCC AGG CTG CTC CAG AAA 3′, and 
MAO-A R: 5′ GGA CCT GGG CAG TTG TGC 3′. The 
sizes of the amplified fragments were as follows: 239, 209, 
226, and 269 bp. In the 5HTT polymorphism analysis, the 
fragment—including the 44-bp ins/del in the regulatory 
sequence (the presence or lack of 44-bp)—was ampli-
fied. The following primer sequences were used: HTT F: 
5′ GGC GTT GCC GCT CTG AAT GC 3′, and HTT R: 5′ 
GAG GGA CTG AGC TGG ACA ACC AC 3′. The sizes of 
the amplified fragments were 484 and 528 bp.
Statistical analysis was performed using Statistica 7.1 
PL. The following tests were applied: the Chi square 
independence test, the Kruskal–Wallis test, Pearson’s 
linear correlation coefficient, and the multiple compari-
son test, showing  which groups differ from each other 
if the Kruskal–Wallis test demonstrated significant dif-
ferences between at least two groups. The significance 
level was set at α =  0.05. The gene polymorphisms did 
not show significant deviations from Hardy–Weinberg’s 
Equilibrium. The study described in the article has been 
carried out in accordance with The Code of Ethics of the 
World Medical Association (Declaration of Helsinki) 
and was approved by the Bioethical Commission of the 
Pomeranian Medical University in Szczecin, Poland (Per-
mission Number KB-0012/155/13).
Results
The mean age of the women was 56.8 ± 4.08 years. Nearly 
half of them (47.7 %) had secondary education, 36.4 %—
higher education. The majority of the respondents lived 
in cities with a population of more than 100,000 residents 
(61.7 %). Most women in the study (69.2 %) had life part-
ners. Greater than half of the respondents (53.3 %) were 
professionally active. Low and medium levels of neuroti-
cism were noted in 77.9 % of the women, and high levels 
in 22.1  %. About half of the women had medium levels 
and about 40  %—high levels of extroversion, agreeable-
ness and conscientiousness. Medium levels of openness 
to experience were observed in 41.5 % of the respondents 
and high levels in 46.9 %.
Furthermore, we evaluated quality of life using the 
SF-36 questionnaire. The highest scores were obtained 
on physical functioning (79.07  ±  19.43), emotional 
functioning (74.84  ±  38.85), and social function-
ing (74.64  ±  23.31). The lowest scores were obtained 
on the vitality domain (57.26  ±  15.19), role physical 
(57.32 ± 42.92), and on general health (59.57 ± 18.66).
The results were statistically analysed with regard to the 
genotype distribution of the 44-bp VNTR polymorphism 
in the 5-HTT (SLC 6A4) promoter region and the expres-
sion of personality traits according to the NEO-FFI. The 
analysis conducted using the Kruskal–Wallis test did not 
reveal any statistically significant differences (Table 1).
Similarly, the statistical analysis conducted using the 
Kruskal–Wallis test with regard to the genotype distri-
bution of the 30-bp VNTR polymorphism in the MAO-
A promoter region and the levels of personality traits 
according to the NEO-FFI demonstrated that the geno-
type distribution of the 30-bp VNTR polymorphism in 
the MAO-A promoter region had significant effects on 
the level of openness to experience (p < 0.05) (Table 1). 
Further analysis based on the test of multiple compari-
sons showed that women with the 3/3 genotype were 
characterized by significantly lower levels of openness to 
experience than respondents with other MAO-A geno-
types (p < 0.05) (Table  2).
We analyzed the influence of personality traits on the 
QoL of the surveyed, and found that the levels of neu-
roticism and extroversion positively correlated with all 
SF-36 QoL domains. We also observed a positive correla-
tion between the level of agreeableness and all SF-36 QoL 
domains, except for the bodily pain domain, and positive 
correlations between the level of conscientiousness and 
the domains of physical functioning, vitality, social func-
tioning, role emotional, and mental health. There was no 
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statistically significant correlation between the women’s 
QoL and the openness to experience level (Table 3).
Discussion
Numerous studies conducted so far confirm the influence 
of genetic factors on personality. Many of them describe 
the role that the MAO-A gene polymorphisms play in the 
evolution of personality traits. The analysis of 277 women 
and men, performed by Chester et al., demonstrated that 
the presence of the low activity MAO-A predisposes to 
aggressive behaviour and acting on negative impulses 
[19]. According to Caspi et al., individuals with the low-
activity MAO-A genotype who were hurt and maltreated 
in their childhood significantly more often develop con-
duct disorders and display antisocial behaviour than 
their counterparts with the high-activity MAO-A geno-
type [20]. These findings were supported by Foley et  al. 
and Nilsson et al. [21, 22]. Other researchers assert that 
people with the low-activity MAO-A and the 5-HTTLPR 
l/l genotype are less impulsive than those with the low-
activity MAO-A and the s/s genotype [23]. It was also 
found that men with the low activity MAO-A gene have 
higher levels of neuroticism [24], and women with the 
high activity MAO-A have higher levels of anxiety and 
suffer from more severe depression [25, 26]. Additionally, 
there are reports that the MAO-A genotype contributes 
to the occurrence of antisocial behaviour among female 
teenagers with alcohol problems [27]. Our study did not 
provide evidence for the impact of the investigated gene 
polymorphisms on the levels of personality traits. The 
only exception was the 3/3 genotype of the 30-bp VNTR 
polymorphism in the MAO-A promoter region, whose 
presence contributed to a higher openness to experience 
level.
The presence of the ‘s’ allele of the 5-HTT gene may 
be associated with a higher tendency to anxiety, as well 
as avoidant and impulsive behaviour [7–9]. The study 
based on magnetic resonance imaging (MRI) demon-
strated that carriers of one or two low transcriptional 
activity alleles (the s/s or s/l genotype) had higher neu-
ronal activity of the amygdala responsible for negative 
emotions, aggression, and defence reactions in response 
to stressful life events, than their counterparts with a 
higher transcriptional activity allele (the l/l genotype) 
[28]. Some researchers claim that girls carrying the ‘s’ 
allele and getting no support from their families more 
often behave without inhibitions and engage in impetu-
ous and ill-considered actions. At the same time, family 
relationships were proved to have no influence on the 
occurrence of impulsive behaviours in girls with the ‘l’ 
allele [29]. Our study did not reveal any statistically sig-
nificant differences in the genotype distribution of the 
44-bp VNTR polymorphism in the 5-HTT (SLC 6A4) 
promoter region depending on the levels of personal-
ity traits as gauged by the NEO-FFI. Similar results were 
obtained by Stein et al., who searched for the connection 
between the 5-HTTLPR gene polymorphism and the 
level of neuroticism (a statistically significant relation-
ship was not demonstrated) [7]. Gingnell et al. reported 
that high neuroticism was more common among women 
suffering from premenstrual dysphoric disorder (PMDD) 
than in the group of healthy females. What is more, anxi-
ety and the lack of assertiveness were more common 
among women with the ‘s’ allele than those with the ‘l’ 
allele [30]. Jacob et al. found that the levels of neuroticism 
were higher in a group of patients with type C personality 
disorders who carried the ‘s’ allele than in those without 
this allele. The study did not reveal differences in the dis-
tribution of the 5-HTT genotypes between respondents 
with types A and B personality disorders and those in the 
control group [31].
There is no doubt that the quality of women’s lives dete-
riorates in the perimenopausal period. The contribution 
of climacteric symptoms to a decline in the quality of life 
(especially psychosocial, physical and sexual spheres) has 
been confirmed by many studies [32, 33]. Little attention 
has been so far paid to personality, which undoubtedly 
plays a role in the QoL assessment. Van Straten et al. used 
the SF-36 questionnaire to measure the QoL of 640 out-
patients with mood and anxiety disorders with regard to 
personality factors. They found that all personality traits 
according to the NEO-FFI, except for conscientiousness, 
were closely related to the QoL. The level of agreeable-
ness was related to the assessment of physical and social 
domains, while the levels of neuroticism, extrover-
sion, and openness to experience were related to mental 
domain. The low QoL level was not only associated with 
mood and anxiety disorders but also these personality 
traits which are relatively stable throughout life [34]. In 
the study of 442 primary care patients, aged 65 years or 
more, conducted using the NEO-FFI and the SF-36, high 
levels of neuroticism were accompanied by lower QoL in 
the physical sphere. High levels of conscientiousness, on 
the other hand, were associated with higher SF-36 scores 
[35]. The study of over 5000 adults, aged 50 years, carried 
Table 2 Multiple comparison test results for  openness 
to experience and MAO-A genotypes
p level of significance
p Value for multiple comparisons
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out by Cheng et  al. revealed a significant relationship 
between personality traits and the QoL assessment [36]. 
Extroversion and conscientiousness were significantly 
related to the QoL in the study group. Besiland et al. ana-
lysed factors contributing to the QoL of 260 patients after 
surgical treatment for kidney cancer. In this analysis, the 
QoL was the lowest assessed by patients with neurotic 
personality and avoidant attitudes [37].
In our study, neuroticism and extroversion affected 
all QoL domains, agreeableness influenced all domains 
except for bodily pain, and conscientiousness had effects 
on all domains except for physical functioning, general 
health and vitality. There was no relationship between 
QoL and openness to experience.
Quality of life can be perceived as a subjective assess-
ment of different aspects of human functioning. Per-
sonality is a factor which determines actions taken by 
individuals and their tendency to perceive reality in a 
particular way. Therefore, the assumption that personal-
ity may influence the QoL assessment seems reasonable. 
Our findings confirm that personality traits have effects 
on various QoL aspects. Based on our results and those 
reported by other authors, it can be asserted that QoL 
does not depend exclusively on health status and life situ-
ation, but also personality traits which are relatively sta-
ble throughout life.
Conclusions
1. Women with the 3/3 genotype of the 30-bp VNTR 
polymorphism in the MAO-A promoter region are 
characterized by lower levels of openness to experi-
ence than women with other MAO-A genotypes in 
our study.
2. Personality traits may contribute to the assessment of 
the quality of life.
Our findings suggest that either monoamine imbal-
ance—associated with the presence of the 30-bp VNTR 
polymorphism in the MAO-A promoter region and the 
44-bp VNTR polymorphism in the 5-HTT (SLC 6A4) 
promoter region—has no influence on the QoL of post-
menopausal women, or the relationships between these 
polymorphisms, QoL, and personality traits were not 
observed because the study involved only healthy women 
(those with mental disorders were excluded).
Limitations
The size of the study sample does not let us draw the con-
clusions for the whole population.
Another limitation of the study is the lack of personal-
ity assessment according to the Structured Clinical Inter-
view for DSM-IV Disorders (SCID), which would allow 
us to make the major DSM-IV Axis I diagnosis.
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